Articles Tagged With:
-
Quinacrine for Refractory Giardiasis
Quinacrine is highly effective in the treatment of giardiasis that is recalcitrant to initial therapy with other agents, but patients must be warned about neuropsychiatric effects. -
The Use of Proton-Pump Inhibitors and the Risk of Acquiring Community-Associated Clostridioides difficile Infection
A nationwide cohort study of adults in Denmark found that proton-pump inhibitor (PPI) use was associated with a moderately increased risk of community-associated Clostridioides difficile infection, and the risk remained elevated up to one year after PPI treatment had stopped. -
Amebic Meningoencephalitis
Primary amebic meningoencephalitis is a rarely diagnosed worldwide disease associated with exposure to fresh water that causes highly lethal, rapidly progressive central nervous system infection but may be treatable in some cases, necessitating maintenance of a high index of suspicion in appropriate cases. -
Clostridioides difficile Infection: Guideline Update
Fidaxomicin is preferred over vancomycin for both initial and recurrent cases. Bezlotoxumab is recommended in many cases of recurrent infection and initial infection in patients at high risk of recurrence. -
COVID-19 Vaccination: The Heart of the Matter
The occurrence of myocarditis after receipt of COVID-19 mRNA vaccines is most frequent in young males and generally is benign, with rapid resolution with only supportive care. Careful analysis indicates that the benefit of vaccination outweighs the risk in all groups for whom the vaccine is recommended — including young males. -
MIS-C: Steroids and/or IVIG?
Multisystem inflammatory syndrome in children (MIS-C) can be a devastating post-COVID-19 complication, but treatment seems effective. High-dose steroids and intravenous immune globulin (IVIG) are commonly used, although new studies give conflicting findings as to whether it is best to use both treatments together. -
ID Groups Call for Mandatory COVID Vaccination of Healthcare Workers
The nation’s leading infectious disease groups have issued a joint paper recommending COVID-19 vaccination as a condition of employment for healthcare workers, with limited exemptions.
-
Annual Costs of MDRO Infections: $5 Billion
With healthcare systems across the nation focused on the COVID-19 pandemic, other priorities have largely gone by the wayside, including the formidable and longstanding problem of multidrug-resistant organisms.
-
Major Medical Groups Call for OSHA to Delay COVID-19 Regulation
Many of the nation’s leading medical groups are calling for the Occupational Safety and Health Administration to delay its Emergency Temporary Standard on COVID-19 by at least six months and to extend the comment period.
-
Treatment, Research Centers Trying to Solve Long COVID-19
Lingering COVID-19 symptoms in many patients may be the last and most insidious wave of the pandemic, since people who have been infected experience a prolonged, sometimes changing array of ill effects. The concern is that a subset of these cases will develop a kind of chronic COVID-19 that becomes a lifelong condition.